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Background: Several countries are discussing new legislation on the ban of smoking in public
places, and on the acceptable levels of traffic-related air pollutants. It is therefore useful to estimate
the burden of disease associated with indoor and outdoor air pollution.
Methods: We have estimated exposure to Environmental Tobacco Smoke (ETS) and to air
pollution in never smokers and ex-smokers in a large prospective study in 10 European countries
(European Prospective Investigation into Cancer and Nutrition)(N = 520,000). We report
estimates of the proportion of lung cancers attributable to ETS and air pollution in this population.
Results: The proportion of lung cancers in never- and ex-smokers attributable to ETS was
estimated as between 16 and 24%, mainly due to the contribution of work-related exposure. We
have also estimated that 5–7% of lung cancers in European never smokers and ex-smokers are
attributable to high levels of air pollution, as expressed by NO2 or proximity to heavy traffic roads.
NO2 is the expression of a mixture of combustion (traffic-related) particles and gases, and is also
related to power plants and waste incinerator emissions.
Discussion: We have estimated risks of lung cancer attributable to ETS and traffic-related air
pollution in a large prospective study in Europe. Information bias can be ruled out due to the
prospective design, and we have thoroughly controlled for potential confounders, including
restriction to never smokers and long-term ex-smokers. Concerning traffic-related air pollution,
the thresholds for indicators of exposure we have used are rather strict, i.e. they correspond to
the high levels of exposure that characterize mainly Southern European countries (levels of NO2
in Denmark and Sweden are closer to 10–20 ug/m3, whereas levels in Italy are around 30 or 40, or
higher).
Therefore, further reduction in exposure levels below 30 ug/m3 would correspond to additional 
lung cancer cases prevented, and our estimate of 5–7% is likely to be an underestimate. Overall, 
our prospective study draws attention to the need for strict legislation concerning the quality of 
air in Europe.
Background
From the point of view of public health it is important to
estimate the burden of disease related to different air pol-
lutants, in view of the new legislation that several coun-
tries are now introducing. Environmental tobacco smoke
(ETS) and traffic-related air pollution share a few charac-
teristics: they are widespread exposures in both the devel-
oped and the developing countries; they have several
chemical components in common, in particular Polycy-
clic Aromatic Hydrocarbons; and they have been associ-
ated with increased risks of lung cancer and other diseases.
The relative lung cancer increase is approximately of the
same entity for both (around 20–30%) [1-4]. However,
no single prospective study has tried to assess the effects of
both exposures in the same populations with accurate and
standardized methods, and to estimate the total burden of
lung cancer attributable to the two exposures.
We have estimated exposure to ETS and to air pollution in
the context of the large EPIC study (European Prospective
Investigation into Cancer and Nutrition), and here we
report estimates of the attributable risks at the population
level.
Methods
EPIC (European Prospective Investigation into Cancer
and Nutrition) [5] is a multi-center European study, in
which more than 520,000 healthy volunteers have been
recruited in 10 European countries (Sweden, Denmark,
Norway, Netherlands, UK, France, Germany, Spain, Italy,
Greece) [6]. The cohort includes subjects of both genders,
in the age range 35–74 at recruitment. Recruitment took
place between 1993 and 1998. Dietary information on the
frequency of consumption of more than 120 foods and
drinks has been obtained by a Food Frequency Question-
naire, validated in a pilot phase. At enrollment, weight,
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for each participant. Detailed information has been col-
lected on reproductive history, physical activity, smoking
and alcohol drinking history, medical history, occupa-
tion, education level and other socioeconomic variables;
the questionnaire was printed in two separate versions for
men and women. A computerized central database has
been developed after checking, coding and quality control
procedures.
The lifestyle questionnaire included several questions on
smoking habits. Present exposure to environmental
tobacco smoke (ETS) was investigated by a few questions:
(a) exposure to ETS yes/no; (b) place of exposure (home,
work); (c) number of hours of current exposure; (d)
number of cigarettes smoked by the spouse in the pres-
ence of the index subject; (e) exposure to ETS during
childhood. Only half of the EPIC centers (11/22) (in
France, Italy, Denmark, Sweden, The Netherlands and
Potsdam, Germany) included questions on ETS in the
questionnaire, and most of these collected information
only on items (a) or (b) above.
The EPIC cohort has been followed-up since inception
through Cancer Registries, vital statistics (mortality), and
– in some areas – hospital discharge data. Whenever avail-
able, diagnosis is based on histological confirmation. All
incident cancers and all causes of death are registered and
checked centrally.
We have also nested a case-control study on lung cancer
(newly diagnosed after recruitment) within the EPIC
cohort, aiming at studying the relationship with air pollu-
tion through individual exposure assessment (which was
not feasible for the whole cohort). We included only
never smokers or ex-smokers who quit at least 10 years
before recruitment. We have matched three controls per
case. Matching criteria were gender, age (plus or minus 5
years), smoking status, country of recruitment, and time
elapsed between date of recruitment and date of diagno-
sis. Matching was introduced to allow strict control of
potentially confounding variables, considering that other
risk factors may be stronger than ETS or air pollution. The
study has been approved by the Ethical Committee of the
International Agency for Research on Cancer, and by all
the local Ethical Committees of the participating centers.
Exposure to air pollution was assessed using concentra-
tion data from monitoring stations in routine air quality
monitoring networks. We excluded traffic and industrial
network sites and instead focused on urban or rural back-
ground locations, i.e. the site should be at least 50 meters
away from any major road and at least 100 meters from a
freeway and not located in an industrial area (preferably
in a residential area). Data were obtained through search-
ing AIRBASE, the air pollution database from the Euro-
pean Topic Center on Air Quality in Bilthoven [7]. In
addition we contacted national/local monitoring agencies
using a questionnaire and used Internet sites from
national agencies. The average concentration for O3, SO2,
NO2, CO and PM10 from all background monitoring sta-
tions in the city of residence was assigned to each study
subject. For each home address we also assessed whether
the home was located in a major street (yes/no). Several
studies have documented substantial differences in con-
centration of traffic-related pollutants between traffic and
background locations. For all homes, we used detailed
Internet maps to evaluate whether the home was located
in a major street (yes/no). Details are given in reference
[8].
For ETS we have analyzed the whole cohort by Cox's pro-
portional hazards model, using age as the dependent var-
iable as suggested by Korn et al [9]. Hazard ratios (HR)
were adjusted by gender, smoking habits (former or never
smoker), time since recruitment, country, school years,
energy intake, fruit and vegetables consumption, and
physical activity. In the nested case-control study on air
pollution we have computed odds ratios (OR) and 95%
confidence intervals (CI) in conditional logistic regression
models [10] that included educational level (4 catego-
ries), as a further adjustment variable in addition to
matching variables. We repeated the analyses using the
center of recruitment and smoking duration/amount as
additional adjustment variables. Analyses were performed
with the SAS package (Cary, NC, USA) for a personal com-
puter. Population attributable risks percent (PAR) were
computed as:
G(OR-1)/(G(OR-1)+1)
where G is the proportion of exposed controls [11].
Details on main results, including cotinine measurements
and information on genetic susceptibility, have been pub-
lished previously [6,8]. Here we focus on the public health
impact of both exposure to ETS and air pollution.
Results
Table 1 shows the prevalence of self-reported exposure to
ETS in EPIC (whole cohort). An estimate between 40%
and 60% can be reasonably considered as representative
of most European countries, with the notable exception of
Germany, with a much lower prevalence. These figures are
comparable with those from other previous surveys
[4,12].
Table 2 shows hazard ratios for ETS and odds ratios for air
pollution indicators. Concerning air pollution, we have
found a statistically significant association only withPage 3 of 7
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mates of the OR were 1.05 (95% CI 0.65–1.69; greater or
equal to 27 vs. lower than 27 ug/m3) for PM10, and 1.15
(0.92–1.43; greater or equal to 11 vs. lower than 11 ug/
m3) for SO2. The OR for NO2 was also adjusted for poten-
tial confounding from ETS by including cotinine levels in
the logistic regression models. The cotinine-adjusted OR
was 1.62 (95% CI 0.92–1.43). Among never smokers the
association with NO2 was represented by an OR of 1.09
(CI 0.78–1.52), while in ex-smokers the OR was 1.59
(1.10–2.30). Concerning ETS, the estimates were 1.05 for
never smokers (0.60–1.82) and 2.32 for ex-smokers
(0.94–5.71); after adjustment for smoking duration and
number of cigarettes smoked the relative risk remained
unchanged – for details see [6]. We found little heteroge-
neity among study centers, with a p-value for interaction
with country of 0.94 for ETS and 0.76 for NO2. However,
the sample size did not allow the estimation of risks for
individual centers. The odds ratio for the joint exposure to
both ETS and NO2 was as high as 4.51, but the CI was very
wide (0.46–43.48).
In previous publications we have shown more detailed
analyses stratified by different characteristics of the
cohort, but here we focus only on the main associations
to estimate population attributable risks. On this basis we
estimated for ETS an attributable proportion of 16%
based on the analysis of the whole cohort. In fact, as
shown before [6], the risk is mainly concentrated in work-
related exposures, with a higher attributable risk (around
24%). For air pollution, for which only the case-control
data are available, the estimate is approximately 5–7%
with both indicators used (heavy traffic road and NO2
greater than 30 ug/m3).
Discussion
A previous investigation estimated that approximately 7
per thousand cases of lung cancer could be attributed to
ETS exposure in never smokers (spouses of smokers) [13].
Our figure is much larger, but it is based on both ex-smok-
ers and never smokers. If we consider never smokers, the
Hazard Risk estimate is 1.05 (95% CI 0.60–1.82) and the
attributable risk in the population is 2.5%, still higher
than the mentioned previous estimate. A likely explana-
tion is that the above-mentioned study considered only
exposure at home, whereas in our study the most impor-
tant source of exposure, associated with higher risks, was
exposure at work. The attributable risk for home exposure
in our study, in fact, is 6 per thousand, in line with the pre-
vious estimate. In another recent study among never
smokers only [14], the estimated OR was 1.31 (1.03–
1.67) with a very high proportion of subjects who were
ever exposed to ETS (86%). This gives an attributable pro-
portion as high as 21%. When only exposure at home was
considered, the OR was 1.19 (1.01–1.40), the proportion
exposed 48% and the PAR% 8%; for workplace exposure,
OR = 1.11 (0.94–1.31), proportion exposed 39%, PAR%
4%.
Particularly concerning is the association between child-
hood exposure and the risk of lung cancer in adulthood
(Table 2). As we have previously reported, there was a sta-
tistically significant trend (p = 0.018) with increasing time
of exposure to ETS in childhood, and with a hazard ratio
of 3.63 (95% CI 1.19–11.1211) for daily exposure for
many hours [6]. To our knowledge, ours is the first pro-
spective study to report such association [15,16]. Of
course, the reliability of information on exposure to ETS
in childhood can be questioned, although most people
are expected to recall whether their parents smoked. The
uptake of carcinogens by children exposed to ETS is wide-
spread and quantitatively important [17]. Fetuses and
newborns seem to be particularly susceptible to carcino-
gens. In one study, mother-newborn pairs exposed to high
levels of indoor pollution from coal smoke were investi-
gated [18]. For all markers, including DNA adducts, new-
borns had levels which were higher than in the mothers,
although tranplacental exposure levels were 10-times
lower than the paired mother exposures. In a series of
well-designed experiments, Somers et al [19] reported
increased mutation rates in herring gulls and mice
exposed to air pollution at levels that characterize normal
urban environments.
Our estimate of 5–7% attributable to air pollution (meas-
ured as proximity to heavy traffic roads or exposure to
NO2) is consistent with previous estimates from other
authors [20]. However, both different exposure metrics
and different pollutants have been used for previous esti-
mates. In particular, Kunzli et al [21] used PM10, while
estimates from the American Cancer Society (ACS) study
[22] used PM2.5 as the reference pollutant. The ACS based
the attributable risk calculation on a linear increase in
PM2.5 in the 7.5–50 ug/m3 range. Unfortunately we do
not have PM2.5 data in Genair, due to the sparse availa-
bility of such exposure parameter in Europe. Therefore,
our estimate is compatible but not strictly comparable to
Table 1: Distribution of exposure to Environmental Tobacco 
Smoke in the EPIC cohort 1
No Yes % exposed
France 23821 35433 59.8
Italy 6953 13817 66.5
The Netherlands 7849 13474 63.2
Germany 19279 5592 22.5
Sweden 6673 15455 69.8
Denmark 10216 45786 81.8
1: according to country (exposure at home and/or at work)Page 4 of 7
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with PM10 in our data. SO2 as well (an indicator of long-
term exposure to stationary combustion) was not associ-
ated in a statistically significant manner with lung cancer
in our study, consistently with two Scandinavian lung
cancer investigations [23,24]. A caveat is needed, i.e. we
should consider that our cohort was never meant to be
representative for the general population. This may be
important especially for the estimates of the prevalence of
relevant exposures. The PARs that we have computed
apply to EPIC participants, but should be extrapolated
with caution to lung cancer in non- and past smokers in
the European population at large. However, the preva-
lence estimates we have computed in our study are, at
least for ETS, realistic (with the exception of Germany)
and similar to figures from other surveys. Another limita-
tion of our study-related to the restriction to non-smokers
– is the small number of subjects with the ensuing large
confidence intervals of estimates.
We have excluded current smokers and recent ex-smokers.
An interaction has been previously described between
recent smoking and exposure to air pollution [25], but we
were not able to address it; nor were we able to estimate
the attributable risk due to the joint effect of the two expo-
sures. This is clearly a limitation of our study, which, how-
ever, has the advantage of avoiding confounding through
restriction to never and ex-smokers.
In summary, in our large prospective study we have found
that among never smokers and ex-smokers since at least
10 years lung cancer was associated to self-reported ETS
exposure at the time of recruitment. The proportion of
lung cancers in never- and ex-smokers attributable to ETS
was estimated as between 16 and 24%, mainly due to the
contribution of work-related exposure. Also exposure to
ETS in childhood seemed to be associated with a relatively
high proportion of lung cancers in adulthood; although
this observation needs to be confirmed, it is particularly
relevant for its public health implications. We have also
found that higher exposure to some air pollutants (in par-
ticular NO2) can increase the risk of lung cancer in non-
smokers. We have thoroughly controlled for potential
confounders. Information bias can be ruled out due to the
prospective design. Changes in exposure levels are likely
to have occurred after the cohort recruitment; this and
other measurement errors are likely to lead to a blurring
of the differences between cases and non-cases, i.e. to an
underestimation of the strength of associations. The asso-
ciation with NO2 does not necessarily imply that this sin-
gle pollutant is (more) carcinogenic than others, but
could express the lower degree of exposure misclassifica-
tion with NO2. The hypothesis that NO2 could better rep-
resent, at least in Europe, exposure to other pollutants, e.g.
fine or ultrafine particles, has been extensively discussed,
in particular in the recent revision of the WHO World Air
Quality Guidelines [26]. We have estimated that 5–7% of
lung cancers in European never smokers and ex-smokers
are attributable to high levels of air pollution, as expressed
by NO2 or proximity to heavy traffic roads. The latter indi-
cator has limitations, mainly related to the fact that it is
associated to social class. It should be noticed that the
thresholds for indicators of air pollution exposure we
have used are rather strict, i.e. they correspond to the high
levels of exposure that characterize mainly Southern Euro-
pean countries (levels of NO2 in Denmark and Sweden are
closer to 10–20 ug/m3, whereas levels in Italy are around
30 or 40, or higher). Therefore, further reduction in expo-
sure levels below 30 ug/m3 would correspond to addi-
tional lung cancer cases prevented, and our estimate of 5–
7% is likely to be an underestimate. Overall, our prospec-
tive study draws attention to the need for strict legislation
concerning the quality of air in Europe.
Table 2: Hazard Ratios (HR) (whole cohort) and Odds Ratios 
(OR) (nested case-control study)1
ETS Hazard ratios Controls:
exposed/total
Exposure to ETS
at home and/or at work 1.34 (0.85 to 2.13) 71722/123479 (58%)
PAR% 0.16
ETS at work 1.65 (1.04 to 2.63) 58653/123479 (47%)
PAR% 0.24
ETS at home 1.03 (0.60 to 1.76) 23396/123479 (19%)
PAR% 0.006
ETS in childhood, daily (a) 2.00 (0.94 to 4.28) 10282/60182 (17%)
PAR% 0.14
Air pollution Odds ratios
Living near heavy
traffic road 1.46 (0.89–2.40) 242/1990 (12%)
PAR% 0.05
Exposure to NO2 (b) 1.30 (1.02–1.66) 428/1562 (27%)
PAR% 0.07
(a) Reference category: never or seldom exposed to ETS in childhood; 
never smokers only
(b) more than 30 microgr/m3 vs. less than 30
1: 95% confidence intervals (in parenthesis) for ETS exposure (home 
and/or work), exposure to indicators of air pollution and lung cancer. 
Both OR and HR are adjusted by gender, age (plus or minus 5 years), 
smoking (former or never smoker), country, school years, energy 
intake, fruit and vegetable consumption, and physical activity. PAR% = 
population attributable risk % (see text).Page 5 of 7
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▪ OR: odds ratios
▪ CI: confidence intervals
▪ PAR: population attributable risk
▪ ETS: environmental tobacco smoke
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